Journal of Biological Chemistry · 2000 · 217 citations · 63 references
Life SciencesCell BiologyMolecular BiologyCell SignalingSignal TransductionTranscriptional RegulationCell Signaling NetworksDevelopmental Signaling PathwaysGrowth Factor SignalingOncogenic Signaling PathwaysProtein Kinase CascadesWnt SignalingBeta-catenin RegulationCanonical Wnt PathwayGlycogen Synthase Kinase 3 RegulationGlycogen Synthase Kinase 3 SignalingWnt Signal TransductionWnt Signaling ActivationWnt Signaling CascadesWnt Signaling Modulation
Wnt signaling involves inhibition of glycogen synthase kinase-3β (GSK-3β) and elevation of cytoplasmic β-catenin. This pathway is essential during embryonic development and oncogenesis. Previous studies on both Xenopus and mammalian cells indicate that lithium mimics Wnt signaling by inactivating GSK-3β. Here we show that serum enhances accumulation of cytoplasmic β-catenin induced by lithium in both 293 and C57MG cell lines and that growth factors are responsible for this enhancing activity. Growth factors mediate this effect through activation of protein kinase C (PKC), not through Ras or phosphatidylinositol 3-kinase. In addition, Wnt-induced accumulation of cytoplasmic β-catenin is partially inhibited by PKC inhibitors and by chronic treatment of cells with phorbol ester. Both calphostin C, a PKC inhibitor, and a dominant negative PKC exhibit partial inhibition on Wnt-mediated transcriptional activation. We therefore propose that Wnt signaling to β-catenin consists of two interactive components: one involves inhibition of GSK-3β and is mimicked by lithium, and the other involves PKC and serves to augment the effects of GSK-3β inhibition. Wnt signaling involves inhibition of glycogen synthase kinase-3β (GSK-3β) and elevation of cytoplasmic β-catenin. This pathway is essential during embryonic development and oncogenesis. Previous studies on both Xenopus and mammalian cells indicate that lithium mimics Wnt signaling by inactivating GSK-3β. Here we show that serum enhances accumulation of cytoplasmic β-catenin induced by lithium in both 293 and C57MG cell lines and that growth factors are responsible for this enhancing activity. Growth factors mediate this effect through activation of protein kinase C (PKC), not through Ras or phosphatidylinositol 3-kinase. In addition, Wnt-induced accumulation of cytoplasmic β-catenin is partially inhibited by PKC inhibitors and by chronic treatment of cells with phorbol ester. Both calphostin C, a PKC inhibitor, and a dominant negative PKC exhibit partial inhibition on Wnt-mediated transcriptional activation. We therefore propose that Wnt signaling to β-catenin consists of two interactive components: one involves inhibition of GSK-3β and is mimicked by lithium, and the other involves PKC and serves to augment the effects of GSK-3β inhibition. glycogen synthase kinase-3β protein kinase B phosphatidylinositol 3-kinase 12-O-tetradecanoylphorbol-13-acetate protein kinase C epidermal growth factor dominant negative β-Catenin was originally identified as a cytoplasmic protein that binds to the cell adhesion molecule cadherin in cell-cell junctions where it connects cadherin to the actin cytoskeleton (1.Kemler R. Trends Genet. 1993; 9: 317-321Abstract Full Text PDF PubMed Scopus (884) Google Scholar, 2.Aberle H. Schwartz H. Kemler R. J. Cell. Biochem. 1996; 61: 514-523Crossref PubMed Scopus (721) Google Scholar, 3.Gumbiner B.M. Cell. 1996; 84: 345-357Abstract Full Text Full Text PDF PubMed Scopus (2960) Google Scholar). It is also involved in the Wnt signaling pathway to regulate developmental processes in a variety of organisms, and in tumorigenesis (4.Polakis P. Curr. Opin. Genet. Dev. 1999; 9: 15-21Crossref PubMed Scopus (609) Google Scholar, 5.Eastman Q. Grosschedl R. Curr. Opin. Cell Biol. 1999; 11: 233-240Crossref PubMed Scopus (475) Google Scholar, 6.Cadigan K.M. Nusse R. Genes Dev. 1997; 11: 3286-3305Crossref PubMed Scopus (2242) Google Scholar). In normal or non-stimulated cells, the majority of the β-catenin protein is present in cell-cell junctions with very little in cytoplasmic or nuclear fractions. This is due to rapid turnover of β-catenin promoted by complexes containing the adenomatous polyposis coli protein, GSK-3β,1 and Axin/Conductin (7.Munemitsu S. Albert I. Souza B. Rubinfeld B. Polakis P. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 3046-3050Crossref PubMed Scopus (957) Google Scholar, 8.Rubinfeld B. Albert I. Porfiri E. Fiol C. Munemitsu S. Polakis P. Science. 1996; 272: 1023-1026Crossref PubMed Scopus (1313) Google Scholar, 9.Behrens J. Jerchow B.A. Wurtele M. Grimm J. Asbrand C. Wirtz R. Kuhl M. Wedlich D. Birchmeier W. Science. 1998; 280: 596-599Crossref PubMed Scopus (1121) Google Scholar, 10.Hart M.J. de los Santos R. Albert I.N. Rubinfeld B. Polakis P. Curr. Biol. 1998; 8: 573-581Abstract Full Text Full Text PDF PubMed Google Scholar, 11.Ikeda S. Kishida S. Yamamoto H. Murai H. Koyama S. Kikuchi A. EMBO J. 1998; 17: 1371-1384Crossref PubMed Scopus (1107) Google Scholar, 12.Kishida S. Yamamoto H. Ikeda S. Kishida M. Sakamoto I. Koyama S. Kikuchi A. J. Biol. Chem. 1998; 273: 10823-10826Abstract Full Text Full Text PDF PubMed Scopus (444) Google Scholar, 13.Sakanaka C. Weiss J.B. Williams L.T. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 3020-3023Crossref PubMed Scopus (283) Google Scholar, 14.Nakamura T. Hamada F. Ishidate T. Anai K. Kawahara K. Toyoshima K. Akiyama T. Genes Cells. 1998; 3: 395-403Crossref PubMed Scopus (258) Google Scholar). The N-terminal clusters of serine and threonine residues of β-catenin are putative GSK-3β phosphorylation sites (8.Rubinfeld B. Albert I. Porfiri E. Fiol C. Munemitsu S. Polakis P. Science. 1996; 272: 1023-1026Crossref PubMed Scopus (1313) Google Scholar), which serve as signals for ubiquitin-mediated degradation (15.Orford K. Crockett C. Jensen J.P. Weissman A.M. Byers S.W. J. Biol. Chem. 1997; 272: 24735-24838Abstract Full Text Full Text PDF PubMed Scopus (647) Google Scholar, 16.Aberle H. Bauer A. Stappert J. Kispert A. Kemler R. EMBO J. 1997; 16: 3797-3804Crossref PubMed Scopus (2183) Google Scholar, 17.Munemitsu S. Albert I. Rubinfeld B. Polakis P. Mol. Cell. Biol. 1996; 16: 4088-4094Crossref PubMed Google Scholar). Recently, an F-box protein β-TrCP in a ubiquitin-ligase complex has been shown to be involved in the proteasome-mediated degradation of phosphorylated β-catenin (18.Winston J.T. Strack P. Beer-Romero P. Chu C.Y. Elledge S.J. Harper J.W. Genes Dev. 1999; 13: 270-283Crossref PubMed Scopus (821) Google Scholar, 19.Hart M. Concordet J.P. Lassot I. Albert I. del los Santos R. Durand H. Perret C. Rubinfeld B. Margottin F. Benarous R. Polakis P. Curr. Biol. 1999; 9: 207-210Abstract Full Text Full Text PDF PubMed Scopus (591) Google Scholar, 20.Latres E. Chiaur D.S. Pagano M. Oncogene. 1999; 18: 849-854Crossref PubMed Scopus (380) Google Scholar). However, in the presence of a Wnt signal, a Frizzled family receptor and the downstream component Dishevelled are activated. Dishevelled in turn leads to the inactivation of GSK-3β, causing the accumulation of cytoplasmic β-catenin. High levels of β-catenin in the cytosol result in its translocation into the nucleus and subsequent interaction with the Tcf/Lef family of transcription factors to activate expression of Wnt-responsive genes (6.Cadigan K.M. Nusse R. Genes Dev. 1997; 11: 3286-3305Crossref PubMed Scopus (2242) Google Scholar). Recently, c-myc and cyclin D1 have been identified as target genes of β-catenin (21.He T.C. Sparks A.B. Rago C. Hermeking H. Zawel L. da Costa L.T. Morin P.J. Vogelstein B. Kinzler K.W. Science. 1998; 281: 1509-1512Crossref PubMed Scopus (4102) Google Scholar, 22.Tetsu O. McCormick F. Nature. 1999; 398: 422-426Crossref PubMed Scopus (3275) Google Scholar). In colon cancer cells, adenomatous polyposis coli protein is frequently mutated resulting in elevated levels of cytoplasmic β-catenin (23.Kinzler K.W. Vogelstein B. Cell. 1996; 87: 159-170Abstract Full Text Full Text PDF PubMed Scopus (4300) Google Scholar). In addition, β-catenin mutations have been detected in colon cancer cell lines with wild-type adenomatous polyposis coli protein and other types of cancer (24.Rubinfeld B. Robbins P. El-Gamil M. Albert I. Porfiri E. Polakis P. Science. 1997; 275: 1790-1792Crossref PubMed Scopus (1137) Google Scholar, 25.de La Coste A. Romagnolo B. Billuart P. Renard C.A. Buendia M.A. Soubrane O. Fabre M. Chelly J. Beldjord C. Kahn A. Perret C. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 8847-8851Crossref PubMed Scopus (988) Google Scholar, 26.Zurawel R.H. Chiappa S.A. Allen C. Raffel C. Cancer Res. 1998; 58: 896-899PubMed Google Scholar, 27.Ilyas M. Tomlinson I.P. Rowan A. Pignatelli M. Bodmer W.F. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 10330-10334Crossref PubMed Scopus (442) Google Scholar, 28.Chan E.F. Gat U. McNiff J.M. Fuchs E. Nat. Genet. 1999; 21: 410-413Crossref PubMed Scopus (548) Google Scholar). The majority of these mutations are located in the putative GSK-3β phosphorylation sites (29.Morin P.J. Sparks A.B. Korinek V. Barker N. Clevers H. Vogelstein B. Kinzler K.W. Science. 1997; 275: 1787-1790Crossref PubMed Scopus (3529) Google Scholar, 30.Sparks A.B. Morin P.J. Vogelstein B. Kinzler K.W. Cancer Res. 1998; 58: 1130-1134PubMed Google Scholar). Similarly, these mutations result in stabilization of the β-catenin protein. Intracellular levels of β-catenin are therefore regulated by different signaling pathways and play a central role in both development and tumorigenesis. Lithium has marked effects on the embryonic development and patterning in different organisms including Xenopus andDictyostelium (31.Kao K.R. Elinson R.P. Biol. Cell. 1998; 90: 585-589Crossref PubMed Scopus (32) Google Scholar). In Xenopus embryos, lithium causes axis duplication, resembling a phenotype caused by overexpression of Wnt, dominant negative GSK-3β, or β-catenin (32.Sokol S. Christian J.L. Moon R.T. Melton D.A. Cell. 1991; 67: 741-752Abstract Full Text PDF PubMed Scopus (390) Google Scholar, 33.Pierce S.B. Kimelman D. Development. 1995; 121: 755-765Crossref PubMed Google Scholar, 34.He X. Saint-Jeannet J.P. Woodgett J.R. Varmus H.E. Dawid I.B. Nature. 1995; 374: 617-622Crossref PubMed Scopus (449) Google Scholar, 35.Funayama N. Fagotto F. McCrea P. Gumbiner B.M. J. Cell Biol. 1995; 128: 959-968Crossref PubMed Scopus (500) Google Scholar). In Dictyostelium, lithium alters cell fate determination, resulting in transformation of pre-spore cells into pre-stalk cells (36.Van Lookeren Campagne M.M. Wang M. Spek W. Peters D. Schaap P. Dev. Genet. 1988; 9: 589-596Crossref PubMed Scopus (26) Google Scholar). In isolated rat adipocytes, treatment with lithium leads to increased glycogen synthesis (37.Cheng K. Creacy S. Larner J. Mol. Cell. Biochem. 1983; 56: 183-189PubMed Google Scholar). The action of lithium has been previously attributed to depletion of inositol, based on the observation that lithium inhibits inositol monophosphatase (38.Berridge M.J. Downes C.P. Hanley M.R. Cell. 1989; 59: 411-419Abstract Full Text PDF PubMed Scopus (890) Google Scholar). However, recent observations suggest that lithium may mimic Wnt signaling by direct inhibition of GSK-3β, to the accumulation of cytoplasmic β-catenin Melton D.A. Proc. Natl. Acad. Sci. U. S. A. 1996; PubMed Scopus Google Scholar, V. L. Woodgett J.R. Curr. Biol. 1996; Full Text Full Text PDF PubMed Google Scholar, J. Dev. Biol. 1997; PubMed Scopus Google Scholar). This is with the that GSK-3β is a protein kinase in and a central role in processes including by lithium X. Saint-Jeannet J.P. Woodgett J.R. Varmus H.E. Dawid I.B. Nature. 1995; 374: 617-622Crossref PubMed Scopus (449) Google Scholar, J.R. Cancer Biol. Google Scholar, I. K. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: PubMed Scopus Google Scholar, E. N. Cell. Full Text PDF PubMed Scopus Google Scholar, Woodgett J. H. Cell. 1995; Full Text PDF PubMed Scopus Google Scholar, N. P. J. Biochem. PubMed Scopus Google Scholar, P. D. A. A. B.A. P.J. J. Biochem. PubMed Scopus Google Scholar, J.R. EMBO J. 9: PubMed Scopus Google Scholar). GSK-3β is in However, result in the inhibition of its activity. by and growth factors the phosphatidylinositol 3-kinase pathway and the subsequent protein kinase B activation leads to inhibition of GSK-3β, the N-terminal phosphorylation D.A. P. M. B.A. Nature. 1995; PubMed Scopus Google Scholar). Wnt also leads to of inhibition of GSK-3β not or kinase pathway D. M.J. K. R. Woodgett J.R. T.C. EMBO J. 1996; PubMed Scopus Google Scholar). of protein kinase C have been shown to be involved in Wnt-induced inactivation of GSK-3β D. M.J. K. R. Woodgett J.R. T.C. EMBO J. 1996; PubMed Scopus Google Scholar). PKC has been shown to and GSK-3β in N. K. Woodgett J.R. P.J. J. Biol. Chem. Full Text PDF PubMed Google Scholar). However, the role of PKC activation in Wnt-induced β-catenin accumulation of GSK-3β by Wnt causes cytoplasmic turnover and increased nuclear translocation of and leads to activation of Wnt target However, is that GSK-3β inhibition by or growth factor leads to β-catenin accumulation and transcriptional activation. Here we that growth factors β-catenin accumulation and This is through a signaling pathway that involves of that two different one mimicked by lithium and the other by to Wnt-induced β-catenin and activation of calphostin C, and growth growth and The β-catenin and actin and and cell lines A.M. Mol. Cell. Biol. 1995; PubMed Scopus Google Scholar, Varmus H.E. A.M. Mol. Cell. Biol. PubMed Scopus Google Scholar). Wnt as previously V. Woodgett J.R. Biochem. J. PubMed Scopus Google Scholar). cells the by Nusse mammalian expression and cell lines for and by containing of wild-type containing and dominant negative Clevers The V. Barker N. Morin P.J. D. de R. Kinzler K.W. Vogelstein B. Clevers H. Science. 1997; 275: PubMed Scopus Google Scholar). a dominant negative of was a Cancer P.J. J. Biol. Chem. 1993; Full Text PDF PubMed Google Scholar). and in with serum and was where was and to a previously H. M.A. M. A.M. J. Cell Growth 1997; 8: Google Scholar). cells and in and the cell in and containing a by on for by in a The to for The and the as the cytoplasmic and the of the cytoplasmic was by of protein was by or The protein to in serum with for or and with to the protein on the by by or to the one with of the or of of the the cells into by with different for with and for The by for and of was to expression The was or to protein in was with C57MG cells the The was the and the and of to the cells and for to in for into containing for of cells that are to for of cytoplasmic β-catenin is for its signaling In colon cytoplasmic β-catenin levels and transcription be by the of adenomatous polyposis coli protein or mutations of the putative GSK-3β phosphorylation sites in the N-terminal of β-catenin M. Tomlinson I.P. Rowan A. Pignatelli M. Bodmer W.F. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 10330-10334Crossref PubMed Scopus (442) Google Scholar, P.J. Sparks A.B. Korinek V. Barker N. Clevers H. Vogelstein B. Kinzler K.W. Science. 1997; 275: 1787-1790Crossref PubMed Scopus (3529) Google Scholar, 30.Sparks A.B. Morin P.J. Vogelstein B. Kinzler K.W. Cancer Res. 1998; 58: 1130-1134PubMed Google Scholar). Wnt also causes of GSK-3β and subsequent β-catenin accumulation in the cytosol and nucleus (6.Cadigan K.M. Nusse R. Genes Dev. 1997; 11: 3286-3305Crossref PubMed Scopus (2242) Google Scholar). We serum which has been shown to GSK-3β to a as Wnt D. M.J. K. R. Woodgett J.R. T.C. EMBO J. 1996; PubMed Scopus Google Scholar, Biochem. J. 1993; PubMed Scopus Google Scholar), cytoplasmic β-catenin this cells with in and by of by and cytoplasmic β-catenin was by shown in serum not to cytoplasmic accumulation of β-catenin. However, lithium cytoplasmic β-catenin which is with observations that lithium as a of GSK-3β and leads to the cytoplasmic accumulation of β-catenin Melton D.A. Proc. Natl. Acad. Sci. U. S. A. 1996; PubMed Scopus Google Scholar, V. L. Woodgett J.R. Curr. Biol. 1996; Full Text Full Text PDF PubMed Google Scholar, J. Dev. Biol. 1997; PubMed Scopus Google Scholar). cells with both serum and lithium, a accumulation of cytoplasmic β-catenin in C57MG and 293 cells was and not serum and lithium also transcriptional activation of a with of sites lithium the to lithium serum to activation in 293 indicate that serum by not have a effect on β-catenin the effect of lithium on cytoplasmic β-catenin accumulation and transcriptional activation. In to is responsible for the serum of β-catenin we and different growth of to caused the accumulation of β-catenin by effect with lithium not of growth factors growth growth and for serum partially serum in β-catenin accumulation not and transcriptional activation growth factors play a role in the of serum with lithium on the cytoplasmic β-catenin and transcriptional activation. growth factors to the serum effect on β-catenin we that growth factors by into GSK-3β pathway D.A. P. M. B.A. Nature. 1995; PubMed Scopus Google Scholar, P. D.A. 1997; PubMed Scopus Google Scholar). we a of B.M. P. S. J. Curr. Biol. 1997; Full Text Full Text PDF PubMed Google for serum in the with the the by with be increased by serum in the 293 cells of an of with to activation not Ras is a in the growth factor signaling pathways McCormick F. Curr. Opin. Genet. Dev. 1997; PubMed Scopus Google F. Mol. Dev. 1995; PubMed Scopus Google Scholar). We Ras be involved in with lithium in β-catenin We a cell The cells of cells not We for serum in of β-catenin accumulation by The cells not cytoplasmic β-catenin the cells with In addition, the cytoplasmic β-catenin levels in both the and the cells be elevated to a by treatment with serum and lithium expression of for serum in of β-catenin of the other pathways by serum and growth factors is the PKC PKC is involved in the accumulation of we a of of in with lithium to β-catenin little effect on the cytoplasmic β-catenin lithium the accumulation of β-catenin The of by is to that of suggest that activation of PKC is not for activation of Wnt signaling it Wnt signaling by with We that the serum be due to the activation of we cells with calphostin C, a PKC inhibitor, with serum and shown in treatment of calphostin C inhibited serum of β-catenin treatment of cells with the serum of β-catenin accumulation not treatment of cells with has been shown to the of the of PKC be responsible for the of β-catenin accumulation by Wnt signaling also leads to cytoplasmic β-catenin accumulation by GSK-3β M. D. M. E. Development. PubMed Google Scholar, J. Rubinfeld B. B. Polakis P. Mol. Cell. Biol. 1996; 16: PubMed Scopus Google Scholar). lithium mimics the Wnt signaling in of the of GSK-3β, we serum also the Wnt signaling by β-catenin cells elevated levels of cytoplasmic β-catenin A.M. Mol. Cell. Biol. 1995; PubMed Scopus Google Scholar, Varmus H.E. A.M. Mol. Cell. Biol. PubMed Scopus Google Scholar). However, serum or serum of cells not the levels of cytoplasmic β-catenin accumulation serum not to β-catenin accumulation induced by This observation that lithium is not the for the Wnt and serum or growth factors that leads to accumulation of β-catenin. PKC has been shown to in the inactivation of GSK-3β by Wnt D. M.J. K. R. Woodgett J.R. T.C. EMBO J. 1996; PubMed Scopus Google Scholar). PKC is involved in the β-catenin accumulation induced by we the cells with different PKC inhibitors and the cytoplasmic β-catenin accumulation by of the or cells with of calphostin C for in of the cytoplasmic β-catenin B and not Similarly, chronic treatment of or cells with or treatment of the cells with also to partial inhibition of β-catenin accumulation not β-catenin accumulation by Wnt was also partially inhibited by treatment of calphostin C, as as by chronic treatment of in C57MG and 293 cells C and not the inhibition of β-catenin accumulation by these inhibitors has we the in The was in cells with cells and was partially inhibited by calphostin C in a in cells the the PKC we a dominant negative PKC to it has effect on Wnt-mediated transcriptional activation. In of and it effect on transcriptional activation The expression of caused partial of Wnt-induced transcriptional activation in a it was not as as the dominant negative activation of PKC by not result in accumulation of cytoplasmic we that activation of PKC is not for of Wnt it is an component of Wnt and studies of a pathway has been the Wnt to the transcription factor Wnt binds to its receptor the activation of which in turn leads to the inactivation of GSK-3β (6.Cadigan K.M. Nusse R. Genes Dev. 1997; 11: 3286-3305Crossref PubMed Scopus (2242) Google Scholar). of GSK-3β the phosphorylation and ubiquitin-mediated degradation of β-catenin (18.Winston J.T. Strack P. Beer-Romero P. Chu C.Y. Elledge S.J. Harper J.W. Genes Dev. 1999; 13: 270-283Crossref PubMed Scopus (821) Google Scholar, 19.Hart M. Concordet J.P. Lassot I. Albert I. del los Santos R. Durand H. Perret C. Rubinfeld B. Margottin F. Benarous R. Polakis P. Curr. Biol. 1999; 9: 207-210Abstract Full Text Full Text PDF PubMed Scopus (591) Google Scholar, 20.Latres E. Chiaur D.S. Pagano M. Oncogene. 1999; 18: 849-854Crossref PubMed Scopus (380) Google Scholar). the the inactivation of GSK-3β and β-catenin accumulation have not been It has been that PKC be involved in the inactivation of GSK-3β inhibitors of PKC are of Wnt-mediated GSK-3β inactivation D. M.J. K. R. Woodgett J.R. T.C. EMBO J. 1996; PubMed Scopus Google Scholar). that pathway two one is mimicked by lithium and the other involves It is that and growth factors GSK-3β to a D. M.J. K. R. Woodgett J.R. T.C. EMBO J. 1996; PubMed Scopus Google Scholar, Biochem. J. 1993; PubMed Scopus Google Scholar), cytoplasmic β-catenin accumulation and studies have that signaling growth factors to GSK-3β is and involves D.A. P. M. B.A. Nature. 1995; PubMed Scopus Google Scholar, S.W. J.M. Biochem. J. PubMed Scopus Google Scholar, D.A. J.R. H.E. P. Biochem. J. PubMed Scopus Google that Wnt to GSK-3β is to treatment D. M.J. K. R. Woodgett J.R. T.C. EMBO J. 1996; PubMed Scopus Google Scholar). GSK-3β inactivation is by PKC inhibitors D. M.J. K. R. Woodgett J.R. T.C. EMBO J. 1996; PubMed Scopus Google Scholar). the pathway GSK-3β inhibition to cytoplasmic β-catenin accumulation to be different Wnt signaling and growth factor In the of GSK-3β inhibition is by phosphorylation of on GSK-3β C. P. Biochem. J. 1993; PubMed Scopus Google Scholar, V. Woodgett J.R. Biochem. J. PubMed Scopus Google Scholar, M. P. 1997; PubMed Scopus Google in Wnt GSK-3β is inhibited to of its normal little is the of the inhibition. It is of to Wnt-mediated GSK-3β inhibition is and different of GSK-3β are involved in Wnt Lithium has effects on in organisms (31.Kao K.R. Elinson R.P. Biol. Cell. 1998; 90: 585-589Crossref PubMed Scopus (32) Google Scholar). action of lithium has been shown to mimic Wnt signaling by direct inhibition of GSK-3β causing the accumulation of cytoplasmic β-catenin Melton D.A. Proc. Natl. Acad. Sci. U. S. A. 1996; PubMed Scopus Google Scholar, V. L. Woodgett J.R. Curr. Biol. 1996; Full Text Full Text PDF PubMed Google Scholar, J. Dev. Biol. 1997; PubMed Scopus Google Scholar). In this we the lithium effect on GSK-3β inhibition not and β-catenin accumulation in both 293 and C57MG We that serum or growth factors with lithium to β-catenin and This a that Wnt also with serum or growth factors to accumulation of β-catenin. However, that Wnt-induced β-catenin accumulation is of serum observations that lithium partially mimic the Wnt signaling pathways are involved in the with lithium to cytoplasmic β-catenin We the of and Ras in the of β-catenin PKC is as a component in the Wnt we PKC inhibitors on serum of β-catenin PKC inhibitors the serum The role of PKC is by the observation that a of PKC also with lithium In we identified a pathway PKC that enhances β-catenin It is that a lithium and growth is in the of a inhibition of GSK-3β H. Res. Dev. Res. 1998; PubMed Scopus Google Scholar). as is the of growth is that growth may with lithium in the inactivation of GSK-3β. this we GSK-3β kinase cells or cells and kinase in the presence of of We not inhibition of GSK-3β by serum and lithium not However, the of the in kinase we the of inhibition of GSK-3β by serum and is to the activation of PKC to β-catenin The role of PKC in the Wnt signaling pathway PKC has been shown to and N. K. Woodgett J.R. P.J. J. Biol. Chem. Full Text PDF PubMed Google Scholar). that a PKC or chronic treatment with in of Wnt-mediated inhibition of GSK-3β in D. M.J. K. R. Woodgett J.R. T.C. EMBO J. 1996; PubMed Scopus Google Scholar). In that the not the effect of these PKC inhibitors on Wnt-induced β-catenin the other that treatment with the PKC inhibitors or caused β-catenin accumulation in cell treatment with the PKC calphostin C or of has effect on β-catenin accumulation (15.Orford K. Crockett C. Jensen J.P. Weissman A.M. Byers S.W. J. Biol. Chem. 1997; 272: 24735-24838Abstract Full Text Full Text PDF PubMed Scopus (647) Google Scholar). that β-catenin was partially inhibited by PKC inhibitors and not The may be by the of these inhibitors on of or effects on other It is that are involved in the Wnt-induced GSK-3β inactivation to β-catenin degradation (15.Orford K. Crockett C. Jensen J.P. Weissman A.M. Byers S.W. J. Biol. Chem. 1997; 272: 24735-24838Abstract Full Text Full Text PDF PubMed Scopus (647) Google Scholar, D. M.J. K. R. Woodgett J.R. T.C. EMBO J. 1996; PubMed Scopus Google Scholar). However, the is the recent by and I. J.M. 1999; PubMed Scopus Google Scholar), that the PKC inhibitors and also GSK-3β, β-catenin The of in colon cancer has been in PKC that exhibit and increased Wnt signaling in the W. J. Cell Biol. 1999; PubMed Scopus Google Scholar). Recently, Wnt and Frizzled have been to PKC have effect on expression of β-catenin target other Frizzled of β-catenin target genes not activate PKC M. Moon R.T. Curr. Biol. 1999; 9: Full Text Full Text PDF PubMed Scopus Google Scholar). with the we that as growth factors or that activate not β-catenin accumulation and transcriptional activation. In inhibitors and the dominant negative PKC we that in are not the essential of this calphostin PKC inhibition or PKC in partial inhibition of Wnt-induced β-catenin both calphostin C and the dominant negative PKC partially the Wnt-mediated Tcf/Lef activation. the that PKC activation is not to of it is a component of Wnt pathway that leads to accumulation of β-catenin and transcriptional activation. of β-catenin levels in the cytosol and nucleus as as its transcriptional is with tumorigenesis. the of β-catenin by different signaling pathways the development of to regulate β-catenin We P. H. A. P. P. and H. for and cell We D. and P. for of the We also of for and
63
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Darren A.E. Cross, Dario R. Alessi, Philip Cohen et al. · Nature · 1995 · 5.2K citations
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Patrice J. Morin, Andrew B. Sparks, Vladimír Kořínek et al. · Science · 1997 · 3.9K citations
β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Osamu Tetsu, Frank McCormick · Nature · 1999 · 3.6K citations
Medicine, Cell Biology, Oncology +14
β‐catenin is a target for the ubiquitin–proteasome pathway
Hermann Aberle, Andreas Bauer, Jörg Stappert et al. · The EMBO Journal · 1997 · 2.5K citations